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Studies of U.S. epidemics of community- and health care-associated methicillin-resistant Staphylococcus aureus (MRSA) sug-
gested differences inMRSA strains in adults and those in children. Comprehensive population-based studies exploring these
differences are lacking. We conducted a prospective cohort study of inpatients in Orange County, CA, collecting clinical MRSA
isolates from 30 of 31 Orange County hospitals, to characterize differences inMRSA strains isolated from children compared to
those isolated from adults. All isolates were characterized by spa typing. We collected 1,124MRSA isolates from adults and 159
from children. Annual Orange County population estimates of MRSA inpatient clinical cultures were 119/100,000 adults and
22/100,000 children. spa types t008, t242, and t002 accounted for 83% of all isolates. The distribution of these three spa types
among adults was significantly different from that among children (2 52.29; P< 0.001). Forty-one percent of adult isolates
were of t008 (USA300), compared to 69% of pediatric isolates. In multivariate analyses, specimens from pediatric patients,
wounds, non-intensive care unit (ICU) wards, and hospitals with a high proportion of Medicaid-insured patients were signifi-
cantly associated with the detection of t008 strains. While community- and health care-associatedMRSA reservoirs have begun
to merge, significant differences remain in pediatric and adult patient populations. Community-associatedMRSA spa type t008
is significantly more common in pediatric patients.
Methicillin-resistant Staphylococcus aureus (MRSA) is a majorglobal cause of morbidity and mortality, imposing serious
economic costs on patients and hospitals (1, 6, 7, 13, 26, 53). Prior
to the mid-1990s, MRSA was largely a health care-associated
pathogen, causing infection predominantly in people with fre-
quent or recent contact with health care facilities (health care-
associated MRSA [HA-MRSA]). In the United States, the rates of
MRSA carriage (both asymptomatic and symptomatic) are esti-
mated to be 6 to 12% in general hospital patient populations and
9 to 24% in intensive care unit populations (ICUs) (23, 32, 50).
Although HA-MRSA has long been the primary cause of MRSA
infections, community-associated MRSA (CA-MRSA), which of-
ten causes infections among healthy children and young adults
with no exposure to the health care setting, is becoming increas-
ingly prevalent. The first reports of MRSA isolated from patients
with no identifiable risk factors came from Australia and the
United States in the 1990s (5, 21, 56). Since then, the prevalence of
CA-MRSA has rapidly increased, with reports of CA-MRSA infec-
tion from virtually every geographic region of the world (55, 59).
The incidence of life-threatening invasive infections owing to CA-
MRSA is increasing, and CA-MRSA appears to be particularly
virulent among children (38). Moreover, CA-MRSA has caused
outbreaks in the hospital setting (4, 41, 51), with some reports
suggesting that it may be replacing HA-MRSA (8, 46, 49, 52).
In the United States, the predominant community-associated
MRSAclone is nowUSA300 (defined by spa typing andmultilocus
sequence typing [MLST] as t008 and ST8, respectively), having
rapidly disseminated and replaced USA400 (t128/ST1) since its
appearance in 2000. USA300 has several characteristics that may
offer a selective advantage over otherMRSA clones, both commu-
nity associated (e.g., USA400) and health care associated (e.g.,
USA100 [t002/ST5]). These advantages include (i) a smaller
staphylococcal cassette chromosome mec (SCCmec) element
(usually type IV) than those of health care-associated strains (usu-
ally SCCmec types I to III), which ismore readily transmissible and
may be an advantage in terms of the DNA replication speed; (ii)
fewer antibiotic resistance genes than health care-associated
strains, resulting in a fitness benefit due to the carriage of smaller
or fewer genes; and (iii) a higher growth rate, which may lead to
successful colonization by outcompeting health care-associated
strains (8, 43). Furthermore, the linkage of an arginine catabolic
mobile element with SCCmec type IV in USA300 likely confers
increased fitness and/or pathogenicity (11). Finally, high levels of
expression of regulatory genes associated with the virulence fac-
tors Panton-Valentine leukocidin and alpha-toxin have been
shown for USA300 versus USA400 isolates, whichmay contribute
to the invasiveness of USA300 (39).
The phenotypic and genotypic differences between HA- and
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CA-MRSA strains have been well documented (2, 10, 12, 33, 43),
yet there are few studies that have directly explored the differences
inMRSA strains isolated from adults and those isolated from chil-
dren. Park et al. (44) previously compared a small number of adult
and pediatricMRSA isolates in a SouthKorean hospital and found
a predominance of CA-MRSA isolates among children. A better
understanding of the frequency of community- versus health
care-associated MRSA clones among adults and children, and in
particular the USA300 clone, may inform strategies to prevent
transmission and disease.
Children may have different exposures to MRSA, as they con-
stitute a largely healthy population that is most likely to incur
MRSA infection through skin and soft tissue injuries related to
sports and other play activities (16). This is in contrast to the
chronically and critically ill adult population, which frequents
hospitals andmay encounter health care-associatedMRSA strains
more readily. Furthermore, childrenmay experience different an-
timicrobial drug selection pressure compared to that of adults due
to differences in common disease syndromes and different guid-
ance on antibiotic therapy (9, 44).
Defining the characteristics ofMRSA strains in adults and chil-
dren would provide insight into the spread of MRSA strains, par-
ticularly since there is growing evidence that community and
health care MRSA reservoirs are mixing (28, 30, 34, 49, 52). Fur-
thermore, few studies of adult or pediatric MRSA strains have
involved a population-based sample of strains. We conducted a
prospective cohort study of inpatients in a large metropolitan
county to characterize differences in pediatric and adult MRSA
strains.
MATERIALS AND METHODS
Study.We conducted a population-based, prospective collection of clin-
ical isolates of MRSA from 30 of 31 hospitals in Orange County, CA. This
study was approved by the Institutional Review Board of the University of
California Regents.
Isolate collection. Clinical (nonscreening) isolates of MRSA from
unique adult patients (18 years of age) and unique pediatric patients
(18 years of age) were collected from hospital microbiology laborato-
ries. Hospitals were instructed to collect MRSA isolates from unique pa-
tients up to a total of 100 isolates or for a duration of 12 months, which-
ever came first. In order to have a representative sample ofOrangeCounty
MRSA isolates, we limited isolates in this study to those collected for a
uniform duration of time from adult hospitals. Since the largest adult
hospitals reached 100 isolates over a 5-month period, we restricted the
period of all adult isolate collections to 5 months. All pediatric hospitals
required a 12-month collection period. Nearly all adult isolates were col-
lected between December 2008 and April 2009. Pediatric isolates were
collected between October 2008 and September 2009. Isolates from pa-
tients not admitted to hospitals were excluded from the study. Samples
were batched and delivered to the Orange County Public Health Labora-
tory using soy agar slants. For the repeated confirmation of MRSA, iso-
lates were plated onto selective medium for MRSA (BD CHROMagar).
MRSA strains were stored at65°C in 15% glycerol Brucella broth.
Specimen data and hospital characteristics. Specimen data, includ-
ing patient age in years, specimen source (wound, blood, urine, sputum,
or other), specimen location (ICU or non-ICU), and time of specimen
collection with respect to admission date (hospital onset [HO], 3 days
after admission; community onset [CO],3 days after admission), were
collected. Hospital characteristics were obtained from a California hospi-
tal data set (42), which included annual admissions, hospital type (acute
care versus long-term acute care [LTAC] facility), percentage of
Medicaid-insured patients, and percentage of Hispanic patients. Popula-
tion estimates of adults and children in Orange County were obtained
from the 2010 U.S. Census (57).
Laboratory methods and molecular typing. All strains were shipped
to Imperial College London in the United Kingdom for spa typing and
stored at 80°C. Cells were harvested on blood agar plates (Oxoid) and
incubated at 37°C overnight. DNA was extracted by using a Qiagen
DNeasy Blood & Tissue kit. DNA samples were eluted in 200l of elution
buffer (10 mM Tris-Cl, 0.5 mM EDTA [pH 9.0]) and stored at 20°C.
Following the sequencing of the spa region, spa types were determined by
using Ridom StaphType v2.1 (RidomGmbH,Würzburg, Germany) (20).
To assess spa type diversity and relatedness, cluster analysis of spa types
was performed separately for adult and pediatric isolates by using the
Based upon Repeat Pattern (BURP) algorithm, a built-in feature of the
StaphType software (35).MLST and SmaI pulsed-field gel electrophoresis
(PFGE) were performed on a subset of the isolates (n 171), to confirm
MRSA strain types, according to methods described previously (14, 48).
This subset included one isolate of each spa type and, for the 10 most
common spa types, one isolate from each of the hospitals in which these
spa types were present. Isolates were selected by using a random number
generator. For PFGE, DNA profiles were analyzed by using BioNumerics
software (version 5.0, 2007; Applied Maths). PFGE types were defined
using a similarity coefficient of 78%, and USA100 to USA800 strains were
used as references.
Statistical analyses. Annual adult and pediatric population estimates
of hospitalized patientswith clinicalMRSA cultureswere calculated by spa
type, accounting for the duration of countywide collection. We further
calculated the percentage of MRSA strains from adult versus pediatric
patients that were due to the most common spa types (t008, t242, and
t002) and compared them by using 2 tests. Specimen data for t008, t242,
and t002 isolates were compared by using2 or Fisher’s exact tests and, for
patient age, the Wilcoxon Mann-Whitney test. Simpson’s index of diver-
sity (1 D) was used to compare the genetic diversities of MRSA strains
among adults and children. 1D gives an unbiased measure of the prob-
ability of drawing two different spa types given the distribution of spa
types in a sample (19). The 95%confidence intervals (CIs) were calculated
as described previously (18). We conducted bivariate tests to evaluate the
association of spa type t008 with individual variables, including age
(adult/pediatric), specimen source (particularly wound and blood), time
of specimen collection (community or hospital onset), and ward type
(non-ICU/ICU).We also tested hospital-level variables, including annual
admissions (greater or less than 10,000), LTAC facility, percentage of
Hispanic patients, and percentage ofMedicaid-insured patients. Formul-
tivariate analyses, variables with a P value of 0.1 were entered into a
generalized linear mixedmodel clustered by hospital and were retained at
an  value of0.05 (xtmelogit, STATA release 11, 2009; Stata Corp.).
RESULTS
A total of 1,124 adult and 159 pediatric MRSA isolates were col-
lected over the 5- and 12-month periods, respectively. A summary
of the characteristics of the clinical MRSA strains collected is
shown in Table 1. The median age of adults was 67 years (inter-
quartile range [IQR], 50 to 81 years), and that of children was 2
years (IQR, 1 to 9 years).
t008, t242, and t002 were the predominant spa types in Orange
County, accounting for 83% of all isolates (Table 2). The distribu-
tion of these spa types among adults (t008, 41%; t242, 23%; t002,
19%) was significantly different from that among children (t008,
69%; t242, 9%; t002, 6%) (2 52.29; P 0.001). Annual popu-
lation estimates of clinical inpatient MRSA infections were 119/
100,000 adults and 22/100,000 children. Annual estimates by spa
type were 48/100,000 adults and 15/100,000 children for t008,
27/100,000 adults and 2/100,000 children for t242, and 22/100,000
adults and 1/100,000 children for t002.
According to MLST, the t008 isolates in our study were of the
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prototypic community clone USA300 (t008/ST8), and the t002
isolates were of the prototypic hospital clone USA100 (t002/ST5),
with t242 isolates being identified as ST5 (Table 2). Comparison of
t242 and t002 isolates for the following parameters revealed no
significant difference: the proportion from each specimen source,
the proportion of hospital and community onset, the proportion
collected in ICU and non-ICU wards, and the age distribution of
patients (all P 0.05). Conversely, t008 isolates were significantly
different from t242 and t002 isolates in the same tests (P 0.001).
t242 and t002 isolates shared the most common specimen source,
sputum (34% and 38%, respectively), whereas wounds were the
most common specimen source of t008 isolates (56%). PFGE of a
sample of t242 and t002 isolates showed them to be predomi-
nantly USA100 isolates (data not shown).
BURP analysis of the spa types clustered the majority of adult
isolates (97%) into three spa clonal complexes (spa-CCs) and
most pediatric isolates (96%) into two spa-CCs (Fig. 1). spa types
were clustered with either t008 (spa-CC008; community-
associated strains) or t002 (spa-CC002; health care-associated
strains), but in adults, a further spa-CC with founder t324 was
identified (spa-CC324). Isolates in this spa-CCwere characterized
as ST72 isolates. For both adult and pediatric MRSA isolates,
MLST results showed that all isolates in spa-CC008 were of ST8
and that all isolates in spa-CC002 were of either ST5 or a single-
locus variant, ST105 (spa types t045, t088, and t1791 for the latter).
According to the BURP algorithm, spa types that differ from all
other spa types in the sample by more than 4 repeats, and thus
which cannot be clustered into a spa-CC, are termed singletons.
For adults, 10 (11.2%) spa types (40 [3.6%] isolates) were classi-
fied as singletons, and for children, 4 (18.2%) spa types (6 [3.8%]
isolates) were classified as singletons. spa types of less than 5 re-
peats in length were excluded from the BURP analysis because no
reliable evolutionary history can be inferred from “short” spa
types (35). For adults, 2 (2.2%) spa types (2 [0.2%] isolates) were
excluded, and for children, 1 (4.5%) spa type (1 [0.6%] isolate)
was excluded. The estimated genetic diversity of MRSA isolates
was significantly higher among adults than among children (1-
D 75% versus 51%) (Table 2).
In bivariate analyses, pediatric patients, wound specimens, iso-
lation in a non-ICUward, community-onset timing of collection,
and isolation from a hospital with 10,000 annual admissions
were associated with t008 (USA300) isolates (Table 3). In addi-
tion, admission to a hospital with a high proportion of Medicaid-
insured patients or a high proportion of Hispanic patients was
linearly associated with the recovery of t008 isolates. In multivar-
iate analyses, isolates from pediatric patients, wounds, non-ICU
wards, and hospitals with a high proportion of Medicaid-insured
patients remained significantly associated with spa type t008 (Ta-
ble 4). Isolates from hospitals with a high proportion of Hispanic
patients were significantly more likely to be t008 isolates (20%
higher odds of being a spa type t008 isolate per 10% increase in
numbers of Hispanic patients). However, this finding was col-
linear with hospitals with a high proportion of Medicaid-insured
patients and thus was removed from the multivariate model.
DISCUSSION
We conducted a prospective cohort study of inpatients in a large
metropolitan county in Californian, collecting all clinical MRSA
TABLE 1 Characteristics of clinical MRSA strains isolated from adult
and pediatric patients
Characteristic
No. (%) of isolates
Adulta Pediatricb Total/overall
Total MRSA isolates 1,124 (87.6) 159 (12.4) 1,283 (100)
Specimen source ofc:
Wound/abscess 488 (43.4) 81 (55.9) 569 (44.8)
Sputum 331 (29.4) 27 (18.6) 358 (28.2)
Urine 109 (9.7) 4 (2.8) 113 (8.9)
Blood 104 (9.3) 7 (4.8) 111 (8.8)
Otherd 92 (8.2) 26 (17.9) 118 (9.3)
Intensive care unit collectione 187 (16.7) 17 (11.8) 204 (16.1)
Hospital onset 399 (35.5) 40 (25.2) 439 (34.2)
a Collected for 5 months from hospitals serving adults.
b Collected for 12 months from hospitals serving children.
c Fourteen missing pediatric entries.
d According to brief notes in the data set, “other” specimen sources included the
following anatomical locations or types of specimens: 5 ear; 5 eye; 3 buttock; 2 each of
finger, leg, pleural, and skin; and 1 each of gastrointestinal, sinus, perineum, spleen, and
umbilical for pediatric specimen sources and 8 leg; 7 foot, knee, and medical device
related; 6 groin; 5 abdominal, spinal, and stool; 4 gastric; 4 hand; 3 back, pleural, and
tissue; 2 each of ankle, body fluid, buttock, ear, eye, stump, synovial fluid, and
unknown; and 1 each of drainage, gallbladder, hip, humerus, ileal crest, lung, pancreatic
fluid, skin, and stoma.
e Nineteen missing entries (4 adult and 15 pediatric).
TABLE 2 Ten most frequently found spa types among adult and pediatric patients in Orange County, CAa
Rank
Adult patients Pediatric patients
spa type MLST
No. of
isolates
% of
isolates
Cumulative
% spa type MLST
No. of
isolates
% of
isolates
Cumulative
%
1 t008 8 457 40.7 40.7 t008 8 110 69.2 69.2
2 t242 5 260 23.1 63.8 t242 5 14 8.8 78
3 t002 5 211 18.8 82.6 t002 5 9 5.7 83.7
4 t024 8 19 1.7 84.3 t024 8 3 1.9 85.5
5 t037 8 15 1.3 85.6 t045 5 2 1.3 86.8
6 t127 1 14 1.3 86.8 t068 8 2 1.3 88.1
7 t088 105 12 1.1 87.9 t2689 8 2 1.3 89.3
8 t1737 5 11 1 88.9 t324 72 2 1.3 90.6
9 t306 5 6 0.5 89.4 t622 8 2 1.3 91.8
10 t126 72 5 0.4 89.9 13 others 1 each 0.6 each 100
a The total numbers of spa types were 89 for adult patients and 22 for pediatric patients. Simpson’s index of diversity (1-D) values were 75% (95% CI, 73%, 76%) for adult patients
and 51% (95% CI, 41%, 60%) for pediatric patients. MLST, multilocus sequence type.
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isolates from 30 of 31 hospitals in order to characterize differences
in pediatric and adultMRSA strains. To our knowledge, this is the
first study to assess adult and pediatric MRSA isolates from a
population-based sample across a large region.
Countywide, adult and pediatric clinical MRSA isolates were
dominated by three spa types, two of which were consistent with
the prototypic community- and health care-associated clones
prevalent in the United States (t008 [USA300] and t002
[USA100]). t008 (USA300) was the most common single clone
among both adult and pediatric isolates. Nevertheless, t008 com-
prised a large majority of pediatric isolates, whereas adult isolates
were nearly equally divided among community- and health care-
associated clones.Most other spa types were shown by BURP to be
related to these two dominant clones. The two spa clonal com-
plexes spa-CC008 and spa-CC002 can therefore be thought of as
two distinct groups of isolates representing the major
FIG 1 Relatedness of spa types among adult (A) and pediatric (B) MRSA isolates according to the Based upon Repeat Pattern (BURP) algorithm. Clusters of
linked spa types correspond to spa clonal complexes (spa-CCs). spa types are clustered into a spa-CCwhen their repeat patterns differ by nomore than 4 repeats.
The BURP algorithm sums up “costs” (ameasure of relatedness based on the repeat pattern) to define a founder score for each spa type in a spa-CC. The founder
(blue node) is the spa type with the highest founder score in its spa-CC, and the subfounder (yellow node) is the spa type with the second highest founder score.
spa-CC008 has founder t008. Each node represents a spa type. The node size represents the number of clustered strains that belong to that spa type. The shading
of the branches represents the costs (similarities in repeat patterns) between two spa types; the darker the branch, the lower the cost (more similar repeat patterns).
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community- and health care-associated MRSA strains prevalent
in the United States.
Interestingly, t242/ST5 was slightly more common than t002/
ST5 among both adult and pediatric isolates, despite the predom-
inance of the t002/ST5 hospital clone in the United States. Given
the similarities of t242 and t002 isolates in this study, and the fact
that t242 differs from t002 by only one nucleotide (resulting in a
different spa repeat pattern by one spa repeat), t242/ST5 presum-
ably represents a minor variant of USA100 that has become prev-
alent in Orange County hospitals. t242 has been reported infre-
quently in the literature (24, 25, 60), with just one study reporting
t242 at an endemic level in an Italian hospital (45).
The additional spa clonal complex identified among adult iso-
lates included a community-onset isolate identified as a t324/ST72
isolate, an invasive community-associated MRSA clone reported
for elderly patients in South Korea from 2006 to 2007, just before
our isolate collection began (29). According to the U.S. Census
Bureau, 17.9%of theOrangeCounty population is Asian, approx-
imately 2.9% of which is Korean (57).
There was significantly more genetic diversity among adult
MRSA isolates than among pediatric isolates. This could simply
represent the greater time that health care-associated clones have
had to diversify at the spa locus than community-associated
clones, which have emerged only in the past 2 decades. The greater
MRSA diversity among adults could also be due to different de-
grees of contact; for example, adultsmay havemore diverseMRSA
encounters (travel, work, social venues, and health care facilities)
than young children (schools and day care centers).
The population estimates of clinical MRSA isolates in Orange
County show that there was a 6-fold-higher frequency of inpatient
MRSA clinical cultures among adults than among children. This
pattern was consistent among the three most common spa types,
t008, t242, and t002, and is likely a combination of more frequent
hospitalizations among adults (many of whom were elderly, with
a median age of 67 years) and more frequent MRSA carriage.
In multivariate analyses, community-associated MRSA clone
t008 (USA300) was associated with pediatric patients. In contrast
to adults, children are often healthier and are more likely to en-
counter MRSA in the community through exposure to high-
density environments, such as schools, day cares, camps, and
sporting activities, where close contact may facilitate the spread of
community MRSA strains. In agreement with data from previous
studies, we found that USA300 was associated with wounds,
which is themost commonpresentation for hospitalization due to
community-acquired MRSA infection (2, 17). USA300 was also
associated with hospitals that treat a large fraction of Medicaid-
insured patients, suggesting that community MRSA infections
may be more prevalent among patients from economically disad-
vantaged or high-density areas.
USA300 was also associated with isolation from non-ICU
wards, suggesting that this community strain is occurring in
healthier hosts or is producing infections that are less severe than
those caused by traditional health care-associated strains. Never-
theless, there is ample evidence that community strains are capa-
ble of producing fulminant infections (15, 37, 52). An under-
standing of what component of invasiveness is due to host
comorbidities versus pathogen virulence factors is an area of ac-
tive research.
Interestingly, we did not find that the isolation of t008 was
associated with community-onset clinical isolates (clinical culture
isolated less than 3 days after admission). This finding is likely due
to the fact that the majority of health care-associated carriage or
infection is found upon readmission to hospitals (27). It could
also be explained by community-associated strains that have be-
come endemic in some hospitals (49, 52).
Community- and health care-associated MRSA strains are be-
coming increasingly difficult to distinguish epidemiologically as
community-associated strains continue to penetrate hospital
MRSA reservoirs. Furthermore, it remains unclear whether com-
TABLE 3 Bivariate analyses of variables associated with spa type t008
Variable
% of t008 isolates
2 PThose with characteristic Those without characteristic
Individual
Pediatric 69.81 40.75 47.67 0.001
Community onset 48.10 37.13 14.09 0.001
Non-ICU 47.17 27.45 27.00 0.001
Blood specimen 40.54 44.30 0.58 0.446
Wound specimen 60.04 32.34 96.28 0.001
LTAC 35.21 44.88 2.54 0.111
Hospital level
10,000 annual admissions 38.40 51.52 22.00 0.001
Medicaid-insured patientsa 1.34 (1.21–1.48) 0.001
Hispanic patientsa 1.29 (1.15–1.44) 0.001
a Odds ratio per 10% increase.
TABLE 4 Multivariate analysis of variables associated with spa type t008
Variable Odds ratio SE 95% CI P
Patient/isolate
characteristic
Wound specimen 2.64 0.34 2.06, 3.39 0.001
Pediatric 2.07 0.52 1.26, 3.40 0.004
Non-ICU 1.77 0.32 1.24, 2.54 0.002
Hospital characteristic
% Medicaid-insured
patientsa
1.24 0.06 1.13, 1.35 0.001
a Odds ratio per 10% increase.
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munity clones are adding to or replacing traditional health care-
associated MRSA strains (3, 8, 22, 49). The implication of the
blurred line between community- and health care-associated
MRSA strains may be that efforts to control MRSA transmission
within hospitals will not be effective in controlling community
influx into hospitals. Simultaneous community strategies to limit
MRSA spread are needed. However, much is still unknown about
the acquisition and transmission of CA-MRSA, so improved
knowledge is needed to better guide infection control strategies.
Further studies are needed to ascertain whether community strat-
egies to reduce transmission in children and young adults would
produce benefits across the entire age spectrum.
One limitation of our study is that few individual-level charac-
teristics were available. Also, our study did not account for the
different policies in place at each hospital with regard to when to
obtain clinical cultures. These differences could affect MRSA de-
tection at each hospital and, possibly, the type of MRSA strains
isolated, if clinical cultures were more likely to be obtained for
sicker, older patients. Moreover, our results could have been af-
fected by the potential seasonality of MRSA infections and infec-
tion types due to the different collection periods for adult and
pediatric isolates (largely winter and spring for adult collections,
compared to all seasons for pediatric collections). A seasonality of
S. aureus infections, particularly skin infections, has been ob-
served in pediatric and adult patients in temperate and tropical
environments, with a predominance of infections during summer
and autumn (31, 36, 54, 58). A recent study in Rhode Island found
a 2- to 3-fold-increased incidence of MRSA infections (both CA-
andHA-MRSA) in pediatric patients during the second two quar-
ters of the year over the last decade (36). However, in that same
study, adult CA-MRSA infections showed less seasonal variation
than did pediatric infections, and no variation was observed
among adult HA-MRSA infections. Some studies observed no sig-
nificant seasonality of S. aureus infections, but those studies fo-
cused on bacteremia (40, 47). The collection of both adult and
pediatric MRSA isolates for the same time period, i.e., 12 months,
would have accounted for any potential seasonality effects and/or
other factors that could affect the type and diversity of MRSA
strains isolated.
Mandatory screening of high-risk inpatients was not in place in
California until 2009; therefore, our population estimates are
likely underestimates. In addition, our estimates should not be
construed asmeasures ofMRSA infection among inpatients. Clin-
ical isolates often represent carriagewithout infection. Finally, our
estimates of the index of diversity for adult and pediatric MRSA
isolates may have been influenced by differing sample sizes (18).
In conclusion, our study found that in a large county, MRSA
isolates from hospitalized children were more likely to be of spa
type t008 (USA300). This community-associated spa type was as-
sociatedwith children, wounds, non-ICU care, and admission to a
hospital with a high percentage ofMedicaid-insured patients. De-
spite the association of t008 isolates with children, t008 was still
the most common spa type among adult patients, suggesting that
community-based interventions are needed to stem the influx of
t008 isolates into hospitals.We also found evidence for a prevalent
variant of the USA100 clone (t242/ST5), which has not been re-
ported elsewhere. While community- and hospital-associated
MRSA reservoirs have begun to merge, significant differences re-
main in pediatric and adult patient populations, which may pro-
vide an impetus for different age-based strategies to reduce trans-
mission and disease.
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